Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Cerilliant
Healthtrust
US Army
US Department of Justice
Harvard Business School
Chubb
Cantor Fitzgerald
Baxter

Generated: December 12, 2018

DrugPatentWatch Database Preview

Chartwell Molecular Company Profile

« Back to Dashboard

What is the competitive landscape for CHARTWELL MOLECULAR, and what generic and branded alternatives to CHARTWELL MOLECULAR drugs are available?

CHARTWELL MOLECULAR has eight approved drugs.



Summary for Chartwell Molecular
US Patents:0
Tradenames:8
Ingredients:8
NDAs:8

Drugs and US Patents for Chartwell Molecular

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Molecular CARVEDILOL carvedilol TABLET;ORAL 077474-002 Sep 5, 2007 AB RX No No ➤ Sign Up ➤ Sign Up
Chartwell Molecular SERTRALINE HYDROCHLORIDE sertraline hydrochloride TABLET;ORAL 077162-001 Feb 6, 2007 DISCN No No ➤ Sign Up ➤ Sign Up
Chartwell Molecular RAMIPRIL ramipril CAPSULE;ORAL 078745-002 Jun 18, 2008 AB RX No No ➤ Sign Up ➤ Sign Up
Chartwell Molecular CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077044-001 Nov 5, 2004 AB RX No No ➤ Sign Up ➤ Sign Up
Chartwell Molecular RAMIPRIL ramipril CAPSULE;ORAL 078745-003 Jun 18, 2008 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Harvard Business School
McKinsey
Cerilliant
AstraZeneca
Mallinckrodt
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.